PD-1 checkpoint inhibitors related immune-mediated hepatitis in colon cancer: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...

A patient who developed atrial fibrillation resulting from the failure to adjust their levothyroxine dose after rapid, significant weight loss while on the antiobesity drug tirzepatide (Zepbound) ...

The FDA recently approved the supplemental biologics license application for teclistamab (Tecvayli; Johnson & Johnson) to treat relapsed/refractory multiple myeloma on a biweekly dosing schedule.

One size doesn't fit all—this statement holds true for bodies in general, pant sizes and weight loss journeys. It is also the case for the maximum dose of Ozempic for weight loss. Sure, seeing numbers ...